Guillain–Barré syndrome with unilateral oculomotor nerve palsy and anti-GM3 IgG antibodies
Science Progress · 2026
DOI: 10.1177/00368504251406582 ↗Kurz gefasst
Fallbericht in der Zeitschrift Science Progress, 2026. Verfasst von Minjia Xiao und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Yueyang Central Hospital, Yueyang City, Hunan Province, China. Hauptthemen laut MEDLINE: Guillain-Barre Syndrome, Immunoglobulin G, Autoantibodies, Oculomotor Nerve Diseases. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Guillain–Barré syndrome (GBS) is a life-threatening acute paralytic neuropathy characterized by rapidly progressive limb weakness and bilateral cranial nerve involvement. We report an early 70s male with no relevant medical history diagnosed with anti-GM3 IgG-positive GBS, who developed unilateral oculomotor nerve palsy and autonomic dysfunction during intravenous immunoglobulin (IVIG) therapy, with spontaneous symptom resolution following IVIG completion. Six-month follow-up assessments confirmed complete remission. This case reinforces the therapeutic value of IVIG in GBS patients with specific autoantibody profiles, even when complicated by transient neurological deterioration during treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Yueyang Central Hospital, Yueyang City, Hunan Province, China.
Zitieren
APA
Xiao, M., & Huang, X. (2026). Guillain–Barré syndrome with unilateral oculomotor nerve palsy and anti-GM3 IgG antibodies. Science Progress. https://doi.org/10.1177/00368504251406582
Vancouver
Xiao M, Huang X. Guillain–Barré syndrome with unilateral oculomotor nerve palsy and anti-GM3 IgG antibodies. Science Progress. 2026. doi:10.1177/00368504251406582
BibTeX
@article{Xiao2026,
author = {Xiao, Minjia and Huang, Xiang},
title = {Guillain–Barré syndrome with unilateral oculomotor nerve palsy and anti-GM3 IgG antibodies},
journal = {Science Progress},
year = {2026},
doi = {10.1177/00368504251406582}
}
EUVIMED